|
Market Closed -
Nasdaq
23:00:00 16/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 82.58 USD | +0.21% |
|
-1.17% | -15.11% |
| 07-31 | IRADIMED CORPORATION Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-31 | IRADIMED CORPORATION, Q2 2026 Earnings Call, Jul 31, 2026 |
Company Valuation: IRADIMED CORPORATION
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 570.3 | 355.5 | 598.4 | 697 | 1,238 | 1,056 | - | - |
| Change | - | -37.67% | 68.32% | 16.49% | 77.54% | -14.67% | - | - |
| Enterprise Value (EV) | 570.3 | 355.5 | 598.4 | 697 | 1,238 | 1,056 | 1,056 | 1,056 |
| Change | - | -37.67% | 68.32% | 16.49% | 77.54% | -14.67% | 0% | 0% |
| P/E | 62.4x | 27.7x | 35.2x | 36.7x | 55.6x | 43x | 37.2x | 33x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.7x | 1.1x | 3.3x | 3.3x | 4.43x | 2.4x | 2.6x |
| Capitalization / Revenue | 13.6x | 6.67x | 9.13x | 9.52x | 14.8x | 11.6x | 10.5x | 9.36x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 11.6x | 10.5x | 9.36x |
| EV / EBITDA | - | - | - | - | - | 33.3x | 30.7x | 27x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 35x | 31.2x | 28.4x |
| EV / FCF | - | - | - | - | - | 59.3x | 49.1x | 59.7x |
| FCF Yield | - | - | - | - | - | 1.69% | 2.04% | 1.68% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.74 | 1.02 | 1.35 | 1.5 | 1.75 | 1.92 | 2.22 | 2.5 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 41.81 | 53.3 | 65.56 | 73.24 | 83.81 | 91.2 | 101 | 112.8 |
| EBITDA 1 | - | - | - | - | - | 31.7 | 34.4 | 39.1 |
| EBIT 1 | 9.818 | 15.63 | 20.04 | 21.96 | 26.15 | 30.2 | 33.85 | 37.2 |
| Net income 1 | 9.325 | 12.83 | 17.19 | 19.23 | 22.48 | 24.65 | 28.45 | 32 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 46.21 | 28.29 | 47.47 | 55.00 | 97.28 | 82.58 | 82.58 | 82.58 |
| Nbr of stocks (in thousands) | 12,342 | 12,566 | 12,606 | 12,673 | 12,721 | 12,787 | - | - |
| Announcement Date | 2/4/22 A | 2/2/23 A | 2/8/24 A | 2/13/25 A | 2/10/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 42.92x | - | - | - | 1.05B | |
| 37.84x | 4.74x | 26.13x | 0.34% | 12.42B | |
| 33.17x | 8.35x | 24.92x | 1.32% | 4.18B | |
| 28.19x | 2.59x | 20.92x | 1.22% | 1.17B | |
| -11.39x | - | - | - | 319M | |
| Average | 26.14x | 5.23x | 23.99x | 0.96% | 3.83B | |
| Weighted average by Cap. | 35.68x | 5.45x | 25.50x | 0.63% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IRMD Stock
- Valuation IRADIMED CORPORATION
Select your edition
All financial news and data tailored to specific country editions
